Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.775 USD | +2.02% | -13.01% | -14.35% |
06-10 | William Blair Starts Tenaya Therapeutics With Outperform Rating | MT |
05-16 | Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.35% | 214M | |
+20.43% | 46.93B | |
+37.89% | 39.08B | |
-8.22% | 38.48B | |
+29.61% | 31.01B | |
-12.26% | 26.14B | |
+11.03% | 25.88B | |
+35.19% | 12.53B | |
-6.69% | 11.36B | |
-12.42% | 10.65B |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Insider Buy: Tenaya Therapeutics